ArticleThe American journal of case reports2025
Transcatheter Edge-to-Edge Repair for Severe Acute Mitral Valve Regurgitation in Diffuse Alveolar Hemorrhage: A Case Report.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Diffuse alveolar hemorrhage is rarely associated with acute mitral valve regurgitation. Emerging evidence of transcatheter edge-to-edge repair (TEER) use for treating acute mitral regurgitation has promoted TEER as a promising alternative to mitral valve surgery, owing to reduced mortality and complications. CASE REPORT A 66-year-old female patient with a history of thyroid nodules presented with dyspnea and hemoptysis. Imaging confirmed bilateral pleural effusions, with opacities suggestive of diffuse alveolar hemorrhage, and echocardiography revealed acute severe mitral valve regurgitation. The patient chose TEER over surgical valve replacement. After discharge on apixaban for new-onset atrial fibrillation, she returned a week later with melena and worsening dyspnea. Echocardiography demonstrated recurrent mitral valve regurgitation, and bronchoscopy confirmed diffuse alveolar hemorrhage. Despite aggressive management, the patient died. CONCLUSIONS This case highlights the complexity of managing acute severe mitral regurgitation complicated by diffuse alveolar hemorrhage in a patient requiring anticoagulation. Although a TEER procedure using the Pascal device was performed, the patient's condition continued to deteriorate, underscoring the importance of individualized treatment strategies, as surgical mitral valve replacement may offer more definitive hemodynamic correction in selected cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.